Hallek M, Al-Sawaf O. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures. Am J Hematol. 2021;96:1679–705. https://doi.org/10.1002/ajh.26367.

Article  PubMed  Google Scholar 

Pekarsky Y, Zanesi N, Croce CM. Molecular basis of CLL. Semin Cancer Biol. 2010;20:370–6. https://doi.org/10.1016/j.semcancer.2010.09.003.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sevov M, Rosenquist R, Mansouri L. RNA-based markers as prognostic factors in chronic lymphocytic leukemia. Expert Rev Hematol. 2012;5:69–79. https://doi.org/10.1586/ehm.11.80.

Article  CAS  PubMed  Google Scholar 

Zhang S, Kipps TJ. The pathogenesis of chronic lymphocytic leukemia. Annu Rev Pathol. 2014;9:103–18. https://doi.org/10.1146/annurev-pathol-020712-163955.

Article  CAS  PubMed  Google Scholar 

Sevinc M, Karabulut A, Eskazan AE, Catal Tatonyan S, Ozbek U, Soysal T. The impact and prognostic significance of chronic lymphocytic leukemia upregulated 1 (CLLU1) gene expression in patients with chronic lymphocytic leukemia: a single center experience. Lab Med. 2020;51:259–64. https://doi.org/10.1093/labmed/lmz058.

Article  PubMed  Google Scholar 

Caligaris-Cappio F, Ghia P. The nature and origin of the B-chronic lymphocytic leukemia cell: a tentative model. Hematol Oncol Clin North Am. 2004;18:849–62. https://doi.org/10.1016/j.hoc.2004.04.004.

Article  PubMed  Google Scholar 

Chen L, Li J, Zheng W, Zhang Y, Wu Y, Li L, et al. The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2007;48:1785–92. https://doi.org/10.1080/10428190701534416.

Article  CAS  PubMed  Google Scholar 

Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981;48:198–206. https://doi.org/10.1002/1097-0142(19810701)48:1%3c198::aid-cncr2820480131%3e3.0.co;2-v.

Article  CAS  PubMed  Google Scholar 

Bosch F, Dalla-Favera R. Chronic lymphocytic leukaemia: from genetics to treatment. Nat Rev Clin Oncol. 2019;16:684–701. https://doi.org/10.1038/s41571-019-0239-8.

Article  CAS  PubMed  Google Scholar 

Tausch E, Schneider C, Robrecht S, Zhang C, Dolnik A, Bloehdorn J, et al. Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax. Blood. 2020;135:2402–12. https://doi.org/10.1182/blood.2019004492.

Article  PubMed  Google Scholar 

Deaglio S, Vaisitti T, Aydin S, Ferrero E, Malavasi F. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia. Blood. 2006;108:1135–44. https://doi.org/10.1182/blood-2006-01-013003.

Article  CAS  PubMed  Google Scholar 

Rawstron AC, Bennett FL, O’Connor SJ, Kwok M, Fenton JA, Plummer M, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med. 2008;359:575–83. https://doi.org/10.1056/NEJMoa075290.

Article  CAS  PubMed  Google Scholar 

Buhl AM, Jurlander J, Geisler CH, Pedersen LB, Andersen MK, Josefsson P, et al. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia. Eur J Haematol. 2006;76:455–64. https://doi.org/10.1111/j.0902-4441.2005.t01-1-EJH2530.x.

Article  CAS  PubMed  Google Scholar 

Gonzalez D, Else M, Wren D, Usai M, Buhl AM, Parker A, et al. CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes. Haematologica. 2013;98:274–8. https://doi.org/10.3324/haematol.2012.070201.

Article  PubMed  PubMed Central  Google Scholar 

Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018;131:2745–60. https://doi.org/10.1182/blood-2017-09-806398.

Article  CAS  PubMed  Google Scholar 

Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343:1910–6. https://doi.org/10.1056/NEJM200012283432602.

Article  CAS  PubMed  Google Scholar 

Buhl AM, Jurlander J, Jorgensen FS, Ottesen AM, Cowland JB, Gjerdrum LM, et al. Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia. Blood. 2006;107:2904–11. https://doi.org/10.1182/blood-2005-07-2615.

Article  CAS  PubMed  Google Scholar 

Josefsson P, Geisler CH, Leffers H, Petersen JH, Andersen MK, Jurlander J, et al. CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia. Blood. 2007;109:4973–9. https://doi.org/10.1182/blood-2006-11-054916.

Article  CAS  PubMed  Google Scholar 

Smolej L. The prognostic role of CLLU1 in chronic lymphocytic leukaemia. Eur J Haematol. 2006;77:177. https://doi.org/10.1111/j.1600-0609.2006.00694.x.

Article  PubMed  Google Scholar 

Oppliger Leibundgut E, Rogenmoser-Dissler D, de Beer D, Porret NA, Zibellini S, Durig J, et al. CLLU1 expression distinguishes chronic lymphocytic leukemia from other mature B-cell neoplasms. Leuk Res. 2012;36:1204–7. https://doi.org/10.1016/j.leukres.2012.05.015.

Article  CAS  PubMed  Google Scholar 

Grzybowska EA, Wakula M. Protein binding to cis-motifs in mRNAs coding sequence is common and regulates transcript stability and the rate of translation. Cells. 2021;10:2910. https://doi.org/10.3390/cells10112910.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buhl AM, Novotny GW, Josefsson P, Nielsen JE, Pedersen LB, Geisler C, et al. The CLLU1 expression level is a stable and inherent feature of the chronic lymphocytic leukemia clone. Leukemia. 2009;23:1182–6. https://doi.org/10.1038/leu.2009.16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jebaraj BM, Kienle D, Lechel A, Mertens D, Heuberger M, Ott G, et al. Telomere length in mantle cell lymphoma. Blood. 2013;121:1184–7. https://doi.org/10.1182/blood-2012-08-452649.

Article  CAS  PubMed  Google Scholar 

Buhl AM, James DF, Neuberg D, Jain S, Rassenti LZ, Kipps TJ. Analysis of CLLU1 expression levels before and after therapy in patients with chronic lymphocytic leukemia. Eur J Haematol. 2011;86:405–11. https://doi.org/10.1111/j.1600-0609.2011.01588.x.

Article  PubMed  PubMed Central  Google Scholar 

Matsuda K. PCR-based detection methods for single-nucleotide polymorphism or mutation: real-time PCR and its substantial contribution toward technological refinement. Adv Clin Chem. 2017;80:45–72. https://doi.org/10.1016/bs.acc.2016.11.002.

Article  CAS  PubMed  Google Scholar 

Shen J, Wang Q, Liang C, Su X, Ke Y, Mao Y, et al. Novel Insights into miR-944 in cancer. Novel Insights Cancers (Basel). 2022;14:4232. https://doi.org/10.3390/cancers14174232.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu L, Qu X. Cancer biomarker detection: recent achievements and challenges. Chem Soc Rev. 2015;44:2963–97. https://doi.org/10.1039/c4cs00370e.

Article  CAS  PubMed  Google Scholar 

Romero D. MRD to help assess response in CLL. Nat Rev Clin Oncol. 2019;16(2):68. https://doi.org/10.1038/s41571-018-0159-z.

Article  PubMed  Google Scholar 

Sampath D, Calin GA. miRs: fine-tuning prognosis in CLL. Blood. 2009;113:5035–6. https://doi.org/10.1182/blood-2009-02-205419.

Article  CAS  PubMed  Google Scholar 

Wos J, Szymanska A, Lehman N, Chocholska S, Zarobkiewicz M, Pozarowski P, et al. Can galectin-3 be a novel biomarker in chronic lymphocytic leukemia? Cells. 2023;3:30. https://doi.org/10.3390/cells13010030.

Article  CAS  Google Scholar 

Hallek M. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. Am J Hematol. 2019;94:1266–87. https://doi.org/10.1002/ajh.25595.

Article  PubMed  Google Scholar 

Deaglio S, Vaisitti T, Aydin S, Bergui L, D’Arena G, Bonello L, et al. CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential. Blood. 2007;110:4012–21. https://doi.org/10.1182/blood-2007-06-094029.

Article  CAS  PubMed  Google Scholar 

Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson FK, et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood. 2002;99:1023–9. https://doi.org/10.1182/blood.v99.3.1023.

Article  CAS  PubMed